KOMISJA NADZORU FINANSOWEGO
Raport bieżący nr19/2021
Data sporządzenia: 2021-12-01
Skrócona nazwa emitenta
MILESTONE MEDICAL
Temat
Adoption of CompuFlo® Epidural Instrument for Pain Management by Dr. Miguel de la Garza, President of the Florida Society of Interventional Pain Physicians and Renowned Physician at Surgery Partners
Podstawa prawna
Art. 17 ust. 1 MAR - informacje poufne.
Treść raportu:
The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company", “the Issuer"), today announced that Dr. Miguel de la Garza has begun incorporating the CompuFlo® Epidural instrument into his practice for pain management, following approval by Surgery Partners, one of the largest and growing surgical services business in the country. Dr. de la Garza plans to utilize the CompuFlo Epidural instrument for both surgical cases and office based procedures to safely and quickly access the epidural space. Dr. de la Garza, a recognized expert in pain management, is the current president of the Florida Society of Interventional Pain Physicians, which is one of the largest pain societies in the United States, representing 400 interventional pain management specialists in the state of Florida. He is a partner at Comprehensive Pain Management Partners in Tampa, Florida, and performs his clinical pain management procedures at Surgery Partners. Founded in 2004, Surgery Partners has over 4,000 affiliated physicians, and more than 180 locations in 31 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities. The Board of Directors of the Company appreciates the support of Dr. Miguel de la Garza who is a leader in the field of pain management. The Board of Directors of the Company is also pleased to announce that Surgery Partners has approved the CompuFlo Epidural instrument for use across their network in pain management. This latest agreement marks a major step in our goal of expanding the addressable market for CompuFlo Epidural instrument beyond labor and delivery. In the opinion of the Board of Directors of the Company the CompuFlo Epidural instrument has the potential to capture a significant share of this market given its safety, reduced risk of complications and cost savings.
MESSAGE (ENGLISH VERSION)
MILESTONE MEDICAL INC
(pełna nazwa emitenta)
MILESTONE MEDICAL
(skrócona nazwa emitenta)(sektor wg. klasyfikacji GPW w W-wie)
NJ 07039.
(kod pocztowy)(miejscowość)
South Orange Avenue Livingston220
(ulica)(numer)
+11 973 535 2717+11 973 535 2829
(telefon)(fax)
(e-mail)(www)
27-5484393
(NIP)(REGON)
PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
DataImię i NazwiskoStanowisko/FunkcjaPodpis
2021-12-01Keisha Harcum Controller Keisha Harcum